Cohen & Steers Total Return Realty Fund, Inc. (RFI) Is At $12.39 Formed Wedge; Profile of 4 Analysts Covering Emergent BioSolutions Inc. (EBS)

June 14, 2018 - By rebbecca

Emergent BioSolutions Inc. (NYSE:EBS) Logo

Among 7 analysts covering Emergent Biosolutions (NYSE:EBS), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Emergent Biosolutions had 12 analyst reports since August 10, 2015 according to SRatingsIntel. Wells Fargo initiated the shares of EBS in report on Friday, February 19 with “Outperform” rating. On Tuesday, February 27 the stock rating was maintained by Singular Research with “Buy”. The stock has “Buy” rating by Cantor Fitzgerald on Monday, June 11. Wells Fargo downgraded it to “Hold” rating and $5600 target in Tuesday, April 24 report. The firm has “Hold” rating given on Friday, July 14 by Cowen & Co. The stock has “Buy” rating by Singular Research on Tuesday, June 28. The company was initiated on Monday, March 28 by Singular Research. The rating was initiated by Chardan Capital Markets on Friday, April 15 with “Buy”. The stock has “Hold” rating by Zacks on Monday, August 10. See Emergent BioSolutions Inc. (NYSE:EBS) latest ratings:

13/06/2018 Broker: Argus Research Rating: Buy New Target: $62 Initiates Coverage On
11/06/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $62.0000 Initiate
24/04/2018 Broker: Wells Fargo Rating: Hold New Target: $56.0000 Downgrade
27/02/2018 Broker: Singular Research Old Rating: Buy New Rating: Buy Old Target: $45 New Target: $60 Maintain
24/01/2018 Broker: Goldman Sachs Rating: Neutral New Target: $55 Initiates Coverage On

Cohen & Steers Total Return Realty Fund, Inc. (RFI) formed wedge up with $12.89 target or 4.00% above today’s $12.39 share price. Cohen & Steers Total Return Realty Fund, Inc. (RFI) has $323.82 million valuation. The stock decreased 1.59% or $0.2 during the last trading session, reaching $12.39. About 88,599 shares traded or 65.43% up from the average. Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI) has declined 3.86% since June 14, 2017 and is downtrending. It has underperformed by 16.43% the S&P500.

Since January 2, 2018, it had 0 buys, and 11 insider sales for $4.28 million activity. $822,615 worth of Emergent BioSolutions Inc. (NYSE:EBS) was sold by Abdun-Nabi Daniel. 1,377 Emergent BioSolutions Inc. (NYSE:EBS) shares with value of $70,434 were sold by Zoon Kathryn C. Richard Ronald had sold 7,893 shares worth $434,115. 1,898 shares valued at $93,951 were sold by Havey Adam on Tuesday, February 27. Hauer Jerome M had sold 8,375 shares worth $436,876. The insider JOULWAN GEORGE A sold $264,448.

The stock increased 3.33% or $1.79 during the last trading session, reaching $55.53. About 374,088 shares traded or 18.20% up from the average. Emergent BioSolutions Inc. (NYSE:EBS) has risen 65.53% since June 14, 2017 and is uptrending. It has outperformed by 52.96% the S&P500. Some Historical EBS News: ; 22/03/2018 – Emergent BioSolutions to Implement Stk Repurchase Program for Up to $50 M of Its Common Stk; 24/05/2018 – Global group taps U.S. biotechs to speed work on Nipah vaccine; 18/05/2018 – Emergent, LLC Exclusively Awarded Small Business DoD Enterprise Software Initiative Contract To Provide Red Hat Solutions; 26/03/2018 – EMERGENT BIOSOLUTIONS INC – APPOINTED RICHARD S. LINDAHL AS COMPANY’S NEW EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER; 31/05/2018 – SPROTT INVESTS IN EMERGENT TECHNOLOGY HOLDINGS; 12/03/2018 – FBO:Veteran Aff: Veterans Affairs Contract Award – Z–Project 590-14-112, SCI Crawlspace Emergent Structural Repairs -; 31/05/2018 – Sprott Inc. Invests In Emergent Technology Holdings; 25/04/2018 – EMERGENT BIOSOLUTIONS INC EBS.N : WELLS FARGO CUTS TO MARKET PERFORM FROM OUTPERFORM; 26/03/2018 – Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy; 19/03/2018 – RITA & ALEX HILLMAN FOUNDATION ANNOUNCES PUBLIC RFP FOR HILLMAN EMERGENT INNOVATION PROGRAM GRANTS

Emergent BioSolutions Inc. focuses on the development, manufacture, and commercialization of medical countermeasures that address public health threats. The company has market cap of $2.77 billion. The Company’s products address public health threats primarily chemical, biological, radiological, nuclear, and explosive-related threats, as well as infectious diseases. It has a 32.55 P/E ratio. The companyÂ’s marketed products include BioThrax, an anthrax vaccine; Anthrasil, a polyclonal antibody for the treatment of inhalational anthrax; BAT for the treatment of botulinum disease; vaccinia immune globulin intravenous that addresses adverse events from smallpox vaccination; reactive skin decontamination lotion kit for the removal or neutralization of chemical warfare agents; and Trobigard, an auto-injector device designed for intramuscular self-injection of atropine sulfate and obidoxime chloride.

More notable recent Emergent BioSolutions Inc. (NYSE:EBS) news were published by: Benzinga.com which released: “Argus: Anthrax Vaccine Maker Emergent BioSolutions Poised For Earnings Growth” on June 13, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare” published on June 12, 2018, Streetinsider.com published: “Cantor Fitzgerald Starts Emergent BioSolutions (EBS) at Overweight” on June 11, 2018. More interesting news about Emergent BioSolutions Inc. (NYSE:EBS) were released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For June 13, 2018” published on June 13, 2018 as well as Globenewswire.com‘s news article titled: “Consolidated Research: 2018 Summary Expectations for PGT, National Commerce, CrossAmerica Partners LP …” with publication date: May 24, 2018.

Investors sentiment decreased to 1.77 in Q1 2018. Its down 0.25, from 2.02 in 2017Q4. It turned negative, as 10 investors sold Emergent BioSolutions Inc. shares while 65 reduced holdings. 56 funds opened positions while 77 raised stakes. 38.34 million shares or 3.95% more from 36.89 million shares in 2017Q4 were reported. 888,811 were reported by Fisher Asset Mngmt Limited Liability Company. Parametric Port Assocs Ltd Limited Liability Company owns 237,330 shares. Ubs Asset Americas accumulated 0% or 43,062 shares. Hodges Management Inc owns 30,000 shares or 0.12% of their US portfolio. Colony Group reported 0.09% in Emergent BioSolutions Inc. (NYSE:EBS). Hillsdale Invest Management has 29,900 shares. 8,066 are held by Zebra Cap Limited Liability Corp. Ftb Advsr holds 150 shares or 0% of its portfolio. Prudential Inc reported 416,921 shares. First Personal reported 0% of its portfolio in Emergent BioSolutions Inc. (NYSE:EBS). Foundry Partners Ltd Liability Corporation accumulated 56,760 shares. M&T Bank reported 0.01% stake. Tiaa Cref Inv Management Limited Liability owns 233,363 shares. Employees Retirement System Of Texas stated it has 116,000 shares or 0.08% of all its holdings. Point72 Asia (Hong Kong) Ltd has 0.01% invested in Emergent BioSolutions Inc. (NYSE:EBS) for 549 shares.

Investors sentiment decreased to 0.65 in Q1 2018. Its down 0.24, from 0.89 in 2017Q4. It dived, as 9 investors sold Cohen & Steers Total Return Realty Fund, Inc. shares while 8 reduced holdings. 4 funds opened positions while 7 raised stakes. 1.94 million shares or 0.81% more from 1.93 million shares in 2017Q4 were reported. Oxbow Advsr Limited Liability Co stated it has 0.12% of its portfolio in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI). Pnc Fincl Svcs Grp owns 14,174 shares for 0% of their portfolio. 71,235 were reported by Schnieders Limited Liability Co. Royal Bancshares Of Canada reported 53,173 shares or 0% of all its holdings. Guggenheim Capital Ltd Llc has invested 0% in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI). Morgan Stanley has invested 0% in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI). First Republic Invest Management owns 0% invested in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI) for 20,000 shares. Cambridge Inv Research Advsrs owns 0% invested in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI) for 24,442 shares. Wells Fargo And Mn reported 354,163 shares stake. Meridian Inv Counsel invested in 0.07% or 10,510 shares. Investment Lc accumulated 10,906 shares or 0.01% of the stock. Baystate Wealth Management Llc has invested 0% of its portfolio in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI). Mcf Advisors Limited Liability Company holds 0.01% of its portfolio in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI) for 5,242 shares. Moreover, Commercial Bank Of America Corp De has 0% invested in Cohen & Steers Total Return Realty Fund, Inc. (NYSE:RFI). 13,000 are held by Chemical State Bank.

Emergent BioSolutions Inc. (NYSE:EBS) Institutional Positions Chart